NCT06116851 Prostate Metabolism, Cancer Risk and Gut Microbiota
| NCT ID | NCT06116851 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Turku University Hospital |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2022-06-01 |
| Primary Completion | 2024-01-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2022-06-01 with a primary completion date of 2024-01-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, single center translational multiple cohort study to investigate the association of gut microbiota and prostate cancer.
Eligibility Criteria
Inclusion Criteria: * Provision of signed and dated informed consent form. * Ability and stated willingness to comply with all study procedures and availability for the duration of the study. Exclusion Criteria: * inability to comply with study procedures or unwillingness to participate in the study.
Contact & Investigator
Peter J. Bostrom, MD, PhD
PRINCIPAL INVESTIGATOR
Turku University Hospital and University of Turku
Frequently Asked Questions
Who can join the NCT06116851 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06116851 currently recruiting?
Yes, NCT06116851 is actively recruiting participants. Contact the research team at peter.bostrom@tyks.fi for enrollment information.
Where is the NCT06116851 trial being conducted?
This trial is being conducted at Turku, Finland, Turku, Finland.
Who is sponsoring the NCT06116851 clinical trial?
NCT06116851 is sponsored by Turku University Hospital. The principal investigator is Peter J. Bostrom, MD, PhD at Turku University Hospital and University of Turku. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.